Vanda Pharmaceuticals Inc. Revenue 2009–2025
Vanda Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Vanda Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 51.7 M, a 3.35% increase year-over-year.
- Vanda Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 210.6 M, a 14.21% increase year-over-year.
- Vanda Pharmaceuticals Inc. annual revenue for 2025 was 216.1 M, a 8.72% increase from 2024.
- Vanda Pharmaceuticals Inc. annual revenue for 2024 was 198.8 M, a 3.18% increase from 2023.
- Vanda Pharmaceuticals Inc. annual revenue for 2023 was 192.6 M, a 24.27% decrease from 2022.
- Vanda Pharmaceuticals Inc. annual revenue for 2022 was 254.4 M.
Vanda Pharmaceuticals Inc. (VNDA) — Frequently Asked Questions
Vanda Pharmaceuticals Inc. (VNDA) is a publicly traded US company. It has a market capitalization of $356M. In fiscal 2025 it reported revenue of $216M and net income of -$220M. Explore VNDA's stock price, financial statements, earnings history, margins and key ratios below.
What is Vanda Pharmaceuticals Inc.'s market cap?
Vanda Pharmaceuticals Inc. (VNDA) has a market capitalization of $356M.
What is the VNDA stock price?
VNDA trades at $6.04 (+0.25% on the day).
How much revenue does Vanda Pharmaceuticals Inc. make?
Vanda Pharmaceuticals Inc. reported revenue of $216M in fiscal 2025.
Is VNDA profitable?
In fiscal 2025, Vanda Pharmaceuticals Inc. reported net income of -$220M.